糖尿病视网膜病变对新生血管性年龄相关性黄斑变性中脉络膜毛细血管的影响
这项前瞻性研究用OCTA比较了伴或不伴糖尿病视网膜病变(DR)的1型黄斑新生血管(MNV)患眼在阿柏西普负荷期前后的脉络膜毛细血管形态改变。共纳入65眼,其中30眼有轻度DR;无糖尿病组在治疗后暗晕周围脉络膜毛细血管环的灌注缺损百分比(FD%)逐渐降低(P=0.003),而DR组两次访视间脉络膜毛细血管参数无显著变化;两组FD%变化量的比较有统计学意义(P=0.029)。
要点
- 无糖尿病组在阿柏西普负荷期后暗晕周围脉络膜毛细血管环FD%逐渐降低,提示脉络膜毛细血管再灌注(P=0.003)。
- DR组两次访视间脉络膜毛细血管参数无显著变化,暗晕周围FD%在T2较T1未见显著降低(P>0.05)。
- 两组FD%变化量的比较有统计学意义(P=0.029),糖尿病眼在治疗前后均表现为更明显的低灌注。
核心结论
- 与1型MNV相关的暗晕周围脉络膜毛细血管在糖尿病眼中于治疗前和负荷期后均较无糖尿病眼表现出更明显的低灌注。
- DR可能是晚期AMD发生和进展的潜在危险因素,也可能影响对抗血管生成治疗的反应。
研究设计与样本
- 前瞻性纳入伴或不伴DR的AMD相关1型MNV患眼。
- 共纳入65眼,其中30眼有轻度DR。
- 在阿柏西普玻璃体内注射负荷期前(T1)和末次注射后1个月(T2)各行3×3 mm OCTA扫描。
- 分析1型MNV周围暗晕外500 µm宽环内脉络膜毛细血管的FD%、FD平均面积和FD数量。
主要发现
- 无糖尿病组抗血管生成治疗后暗晕周围脉络膜毛细血管环FD%逐渐降低,提示脉络膜毛细血管再灌注(P=0.003)。
- DR组两次研究访视间脉络膜毛细血管参数无显著变化,暗晕周围FD%在T2较T1未见显著降低(P>0.05)。
- 两组FD%变化量的比较有统计学意义(P=0.029):无糖尿病组在阿柏西普负荷期后逐渐出现脉络膜毛细血管再灌注,而糖尿病眼无显著变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the impact of diabetic retinopathy (DR) on morphological choriocapillaris (CC) modifications in eyes with type 1 macular neovascularization (MNV) secondary to AMD using optical coherence tomography angiography (OCTA). METHODS: Eyes with AMD-related type 1 MNV with and without DR were prospectively included. We performed 3 × 3 mm OCTA scans at two visits: before the loading phase of intravitreal injections of aflibercept (T1) and 1 month after the last injection (T2). OCTA En face flow images of the CC were analyzed for flow deficit percentage (FD%), FD average area and FD number in a 500-µm-wide ring surrounding the dark halo (DH) around type 1 MNV. RESULTS: A total of 65 eyes, out of which 30 eyes had mild DR, were included. In the group without diabetes, there was a gradual reduction in FD% in the CC ring around the DH after antiangiogenic therapy, indicating reperfusion of the CC (P = 0.003). However, in the DR group, there were no significant changes in CC parameters between the two study visits. Specifically, the FD% in the CC ring around the DH did not show a significant reduction at T2 compared with T1 values (P > 0.05). Furthermore, the comparison of the variation in FD% between the two groups was statistically significant. The nondiabetic group exhibited a gradual CC reperfusion after the loading phase of aflibercept, whereas the diabetic eyes did not show significant changes (P = 0.029). CONCLUSIONS: The CC surrounding the DH associated to type 1 MNV exhibited greater hypoperfusion in diabetic eyes compared with eyes without diabetes, both before starting therapy and after the loading phase. Hence, DR may be a potential risk factor in the development and progression of late-stage AMD and may also influence the response to antiangiogenic therapy.
引用
- Viggiano P, Miere A, Borrelli E, et al. The Impact of Diabetic Retinopathy on the Choriocapillaris in Neovascular AMD. Invest Ophthalmol Vis Sci. 2023. PMID: 37988106. doi:10.1167/iovs.64.14.32
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。